Cocrystal Pharma Inc.

COCP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.22

+$0.01 (+0.83%)

At close: Sep 21, 2026, 3:59 PM ET

$1.19

-$0.03 (-2.46%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-8.83M	-17.5M	-17.98M	-38.84M	-14.19M	-9.65M
Depreciation & Amortization	72K	126K	-1.39M	388K	190K	157K
Stock-Based Compensation	270K	643K	801K	855K	724K	662K
Other Working Capital	-215K	1.36M	296K	-2.39M	240K	-966K
Other Non-Cash Items	3K	110K	1.56M	18.87M	-195K	-177K
Deferred Income Tax	n/a	n/a	n/a	n/a	-49K	54K
Change in Working Capital	294K	140K	2.34M	-2.71M	796K	-878K
Operating Cash Flow	-8.19M	-16.49M	-14.67M	-21.44M	-12.72M	-9.83M
Capital Expenditures	-12K	-8K	-118K	-74K	-52K	-240K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-12K	-8K	-118K	-74K	-52K	-240K
Debt Repayment	n/a	n/a	-7K	-27K	-39K	-121K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	5.37M	n/a	3.99M	-27K	38.47M	35.66M
Net Cash Flow	-2.84M	-16.49M	-10.79M	-21.54M	25.7M	25.59M
Free Cash Flow	-8.2M	-16.49M	-14.78M	-21.51M	-12.77M	-10.07M
Adj. Free Cash Flow	-8.47M	-17.14M	-15.59M	-22.36M	-13.5M	-10.73M
Maintenance CapEx	-12K	-8K	-118K	-74K	-52K	-240K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-8.2M	-16.49M	-14.78M	-21.51M	-12.77M	-10.07M